Syringes with doses of the Johnson & Johnson Janssen COVID-19 vaccine are readied at a Culver City Fire Department vaccination clinic on Aug. 5 in California. Patrick T. Fallon/AFP/Getty Images/TNS

Johnson & Johnson on Tuesday announced it has officially requested the Food and Drug Administration’s approval for a booster shot of its COVID-19 vaccine.

“We’re describing the data to them,” Dr. Mathai Mammen, head of global research and development for J&J’s vaccine arm, Janssen, told CNN.

“The process is not that we asked for a very specific interval — we’re providing them data and we’re going to be presenting to the committee. They’ll take all that into consideration when they ultimately decide on an appropriate interval.”

While health experts have been mostly divided over the necessity for booster shots, particularly while so many people in the United States and beyond have yet to receive their first jab, President Biden and his administration threw their support behind an extra dose back in August — a move he hopes will further establish protection against coronavirus and the delta mutation.

Johnson & Johnson is the third drug-maker to submit a request for booster approval after Moderna and Pfizer. Health officials approved the latter last month and the FDA’s Vaccine and Related Biological Products Advisory Committee is scheduled to meet Oct. 14 and 15 to consider requests from Moderna and Johnson & Johnson.

As an Amazon Associate I earn from qualifying purchases.

Tribune Wire

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.